For further confirmation of our TME flow cytometry data showing CD4 and CD8 T-cell activation, we found an increase in Th1 pro-inflammatory cytokine (IFNγ, TNFα, IL-2, and KC/GRO) levels in the tumor lysate. The gene discussed is CXCL1; the disease is neoplasm.